Investigational new drugThyroid Analog
Compound 61744
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061744
Risk Class
HIGH
Last Audit
Jul 11, 2108
Research Abstract
Thyroid Analog candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61744 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in investigational new drug with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061744 with updates logged 2108-07-11.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61744Thyroid Analog Program 61744
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061744
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61744